Home › Funds › Patient Square Capital LP › ONC

Patient Square Capital LP position in ONC

BEONE MEDICINES LTD · Health Care

Patient Square Capital LP reported holding 33,500 shares of ONC (BEONE MEDICINES LTD) in its Q3 2026 13F filing — a position valued at US$12.3M, representing 1.96% of its reported portfolio and ranking #13 among its reported holdings. Patient Square Capital LP has disclosed ONC holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)33.50K sh
Reported value held$12.26M
Portfolio Weight1.96%
First reportedQ4 2025
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Patient Square Capital LP's ONC position evolved

Patient Square Capital LP first disclosed a stake in ONC in Q4 2025 at 69,312 shares (US$21.1M). The position peaked in Q2 2026 at 90,020 shares, worth US$25.7M. Across 4 filings, Patient Square Capital LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 33,500 shares valued at US$12.3M — a reduction of -56,520 shares quarter over quarter.. Notable position changes include a 63% trim in Q3 2026 (shares rose 14% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 69.31K $21.06M New
Q1 2026 80.54K $23.92M Add
Q2 2026 90.02K $25.65M Add
Q3 2026 33.50K $12.26M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ONC and 13F data

ONC (BEONE MEDICINES LTD) is a Health Care company. 30 other funds we track also report a position in ONC — the largest reported positions include BAKER BROS. ADVISORS LP (US$2.51B), PRIMECAP MANAGEMENT CO/CA/ (US$1.80B), Temasek Holdings (US$241.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ONC

All ONC fund holders →

FAQ

How long has Patient Square Capital LP held ONC?

Patient Square Capital LP has disclosed ONC holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Patient Square Capital LP's current position in ONC?

As of Q3 2026, Patient Square Capital LP holds 33.50K shares of ONC (BEONE MEDICINES LTD), valued at $12.26M, representing 1.96% of its reported portfolio and ranking #13.

Has Patient Square Capital LP been buying or selling ONC?

In the latest 13F filing (Q3 2026), Patient Square Capital LP reduced its position in ONC. The position peaked in Q2 2026 at 90.02K shares.

Which other funds hold ONC?

Other major institutional holders of ONC include BAKER BROS. ADVISORS LP, PRIMECAP MANAGEMENT CO/CA/, Temasek Holdings, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.